The aerial parts (10 kg) were extracted with methanol (15 L × 3 times) at 40 °C using sonication for 5 h. After filtering and removing the solvent via rotary evaporator, the total extract was suspended in distilled water (1 L) and partitioned with CHCl3 (1 L × 4 times), EtOAc (1 L × 4 times), and BuOH, successively. The resulting fractions were concentrated under reduced pressure in a rotary evaporator to give the CHCl3, EtOAc, and BuOH fractions, and a H2O residue, respectively. Following the 2-NBDG assayguided fractionation, the CHCl3 fraction was directly chromatographed on an open silica gel column (10  80 cm; 63200 m particle size, Merck) using a stepwise gradient of n-Hexane/acetone (from 20:1 to 2:1) to give five fractions (OSC-1 to OSC-5), according to their TLC profiles. Fraction 2 (OSC-2) was further fractionated by another open silica gel column (4.0 x 60 cm, 63-200m particle size), eluted with a gradient solvent system of n-Hexane/EtOAc (from 15:1 to 5:1), and afforded five sub-fractions (OSC-2.1 to OSC-2.5). Sub-fraction OSC-2.2 was further purified by the Agilent 1260 HPLC system with an RS Tech Optima PakC18 column (10 × 250 mm, 10 µm particle size), and eluted with an isocratic solvent system of 70% ACN in H2O + 0.1% formic acid (flow rate 2 mL/min) over 40 min, using UV detections at 205 and 254 nm, resulting in the isolation of compound 4 (12.9 mg; tR = 29.6 min). Fraction 3 (OSC-3) was also fractionated by open silica gel column (3.0 × 60 cm, 63-200m particle size), eluted with a gradient solvent system of n-Hexane/EtOAc (from 12:1 to 4:1), and afforded five sub-fractions (OSC-3.1 to OSC-3.5). Sub-fraction OSC-3.3 was further purified by the Agilent 1260 HPLC system with an RS Tech Optima PakC18 column (10 × 250 mm, 10 µm particle size), and eluted with an isocratic solvent system of 65% ACN in H2O + 0.1% formic acid (flow rate 2 mL/min) over 30 min, using UV detections at 205 and 254 nm, resulting in the isolation of compounds 7 (27.8 mg; tR = 19.6 min) and 3 (8.1 mg; tR = 23.8 min), respectively. Fraction 4 (OSC-4) was also fractionated by the same open silica gel column (3.0 × 60 cm, 63-200m particle size), eluted with a gradient solvent system of n-Hexane/EtOAc (from 10:1 to 2:1), and afforded five sub-fractions (OSC-4.1 to OSC-4.5). Purification of sub-fraction OSC-3.2 by the Agilent 1260 HPLC system using an RS Tech Optima PakC18 column (10 × 250 mm, 10 µm particle size) and eluted with an isocratic solvent system of 60% ACN in H2O + 0.1% formic acid (flow rate 2 mL/min) over 40 min, using UV detections at 205 and 254 nm, resulted in the isolation of compound 1 (11.5 mg; tR = 30.1 min) and compound 2 (5.8 mg; tR = 35.6 min), respectively. Finally, compounds 5 (14.6 mg; tR = 13.4 min) and 6 (23.3 mg; tR = 18.1 min) were purified from sub-fraction OSC-4.4 by the Agilent 1260 HPLC system using the same HPLC described previously, and eluted with an isocratic solvent system of 58% ACN in H2O + 0.1% formic acid (flow rate 2 mL/min) over 30 min, respectively. Victor3 V 1420 Multilabel Plate Counter at an excitation and emission wavelength of 485 nm and 535 nm, respectively.
PTP1B Inhibition Assay
Protein tyrosine phosphatase 1B (human recombinant) was purchased from Biomol International LP, Plymouth Meeting, PA, USA, and the inhibitory activities of the tested samples were evaluated using the method as described in [31] . Briefly, 0.05−0.1 µg of PTP1B (BIOMOL International L.P., Plymouth Meeting, PA, USA) and 4 mM p-NPP in a buffer containing 1 mMdithiothreitol, 0.1 M NaCl, 1 mM EDTA, and 50 mM citrate (pH 6.0), with or without test compounds, were added as 100 µL of a final volume to each of the 96 wells. After the reaction mixture was incubated at 37 °C for 30 min, 10 M NaOH was added to quench the reaction. PTP1B enzyme activity was determined by the amount of produced p-nitrophenol at 405 nm. The nonenzymatic hydrolysis of the substrate was corrected by measuring the control, which did not contain the PTP1B enzyme.
Determination of the Inhibition Mode of Active Compounds
The Lineweaver-Burk plot and Dixon plot experiments were carried out in the presence and absence of the inhibitors with various concentrations of p-NPP as the substrate. The inhibition modes of the tested compounds were assessed on the basis of their inhibitory effects on the Km (dissociation constant) and Vmax (maximum reaction velocity) of the enzyme, which were determined by the Lineweaver-Burk plot experiment. The Lineweaver-Burk plot is the double reciprocal plot of the enzyme reaction velocity (V) versus the substrate (p-NPP) concentration (1/V versus 1/(p-NPP)).
Statistical Analysis
Data are represented as means ± SD of at least three independent experiments performed in triplicated assays and determined by regression analysis. For statistical analysis of the data for single comparison, the significance between means was determined by the Student's t test. Sigma Plot program version 11.0 was used for analysis of the kinetic data.
